Home > Publishers > Mellalta Meets LLP
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

Mellalta Meets LLP Report List

mell
Mellalta Meets LLP is a research-based consultancy with a global footprint. They have worked with firms around the world to help optimize business strategy and transform their business decisions. Additionally, they help Pharma & Biotech companies stay on top of the competition, and provide customized intelligence reports.

Filter
Title Search
1 - 20 of 20 Products Sort by Display
Lumbar Radiculopathy (Sciatica)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1031005
Published
October 5, 2021
Content info
181 Pages
Price
USD 6500
Sample available
Complex Regional Pain Syndrome (CRPS)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1031004
Published
October 5, 2021
Content info
147 Pages
Price
USD 6500
Sample available
Mitochondrial Epilepsy (MIT-E) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030730
Published
August 31, 2021
Content info
151 Pages
Price
USD 6500
Sample available
Wolfram Syndrome (WS) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030733
Published
July 31, 2021
Content info
127 Pages
Price
USD 6500
Sample available
Corticobasal Syndrome (CBS) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2030
Published by
Mellalta Meets LLP
Product code
1030732
Published
July 31, 2021
Content info
105 Pages
Price
USD 6500
Sample available
Progressive Supranuclear Palsy (PSP) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030731
Published
July 31, 2021
Content info
144 Pages
Price
USD 6500
Sample available
Peripheral T-cell lymphoma (PTCL)| Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
1015906
Published
June 22, 2021
Content info
190 Pages
Price
USD 6500
Sample available
Adult Acute Lymphoblastic Leukemia (aALL) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
1015905
Published
June 22, 2021
Content info
172 Pages
Price
USD 6500
Sample available
Chimeric Antigen Receptor (CAR-T) Cell Therapy - Market Opportunity, Pipeline & Competitive Intelligence 2020
Published by
Mellalta Meets LLP
Product code
1015904
Published
June 22, 2021
Content info
1,083 Pages
Price
USD 4000
Sample available
Wet Age-related Macular Degeneration (wAMD)| Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997048
Published
March 16, 2021
Content info
166 Pages
Price
USD 6500
Sample available
Obstructive Sleep Apnea (OSA) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997049
Published
February 28, 2021
Content info
152 Pages
Price
USD 6500
Sample available
Central Precocious Puberty | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997046
Published
February 28, 2021
Content info
100 Pages
Price
USD 6500
Sample available
Chronic Kidney Disease (CKD) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997047
Published
January 31, 2021
Content info
232 Pages
Price
USD 6500
Sample available
Schizophrenia | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997050
Published
January 30, 2021
Content info
Price
USD 6500
Sample available
High Grade Intraepithelial Lesion (HSIL) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
999973
Published
January 1, 2021
Content info
114 Pages
Price
USD 6500
Sample available
Acute Kidney Injury (AKI) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997045
Published
November 30, 2020
Content info
137 Pages
Price
USD 6500
Sample available
Hemophilia A Gene Therapy: Key Opinion Leaders (KOLs) Insight - An Executive Report 2020
Published by
Mellalta Meets LLP
Product code
954090
Published
August 18, 2020
Content info
54 Pages
Price
USD 6250
Sample available
Acute Myeloid Leukemia (AML) - The Changing Landscape of Treatment in AML, Executive Deck 2020
Published by
Mellalta Meets LLP
Product code
953774
Published
August 4, 2020
Content info
235 Pages
Price
USD 7500
Sample available
KRAS Inhibitors - Market Opportunity, Epidemiology & Market Forecast, Pipeline and Competitive Analysis, 2020-2030
Published by
Mellalta Meets LLP
Product code
945512
Published
June 30, 2020
Content info
2 PDFs: 121 Pages + 30 Pages
Price
USD 3250
Sample available
T-Cell Receptor (TCR) Therapy - Executive Report 2020
Published by
Mellalta Meets LLP
Product code
945511
Published
November 30, 2019
Content info
311 Pages
Price
USD 3000
Sample available